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Gyrate Atrophy and Choroidal Neovascularization
53-year-o l d , h igh-
myopic white man 
affected with gyrate 
atrophy (GA) was re­
ferred in May 1983 
because of a sudden loss of vision in 
his left eye. His best-corrected visual 
acuities were 20/60 OD and 20/400, 
with a central scotoma, OS. On oph­
thalmic examination, peripheral and 
peripapillary chorioretinal atrophy 
was seen in both fundi. A localized 
neurosensory detachment with cho­
roidal neovascularization (CNV) was 
suspected in the left eye. Conven­
tional fluorescein angiography 
showed a well-defined subfoveal CNV 
(Figure 1). Because of the central lo­
calization of CNV, no laser treat­
ment was advised.
In May 1995, the patient’s vi­
sual acuity was limited to hand move­
ments OU. Ophthalmoscopy of the 
left eye showed chorioretinal atro­
phy involving the central macula. Be­
neath a small, subfoveal, and appar- 
ently fibrotic scar, a triangular 
granular pigmented area was seen. 
Fluorescein angiography still re­
vealed leakage from the central sub- 
retinal lesion, surrounded by atro­
phy of the retinal pigment epithe­
lium and choriocapillaris (Figure 2).
COMMENT
in their study of 29 patients affected 
with GA, Takki and Milton1 concluded 
that the decrease in visual acuity was 
dependent primarily on atrophic 
macular involvement and cataract for­
mation, To our knowledge, no previ­
ous cases of GA associated with CNV 
have been reported to date.
High myopia has to be considered 
as a typical feature of patients affected 
with GA. In a recent study of the clini- 
copathologic features of 123 surgi­
cally removed subretinal membranes, 
Grossniklaus et al2 concluded that 
CNV represents a stereotypical, non­
specific response, regardless of the un­
derlying disease. If one accepts those 
conclusions, the same pathogenetic 
course of CNV as in pathologic myo­
pia might be postulated in our patients 
affected with G A. In both conditions, 
large areas of chorioretinal atrophy
with a relative ischemia-hy poxia con­
dition are present.
Excluding any further compli­
cation, this rare, inherited, chorio­
retinal dystrophy has an unfavor­
able prognosis. Because CNV might 
occur in patients affeetctl with GA, 
further loss of vision may be expe­
rienced during their lifetime.
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Figure 1. Conventional early-phase (left) and late-phase (r(ght) fluorescein angiography performed in 
May 1983 shows a well-defined choroidal neovascularization in the patient's left eye, contiguous to the 
temporal border of the peripapillary chorioretinal atrophic area.
Figure 2, Conventional fluorescein angiography 
performed 12 years later shows some 
sill ¡’evident subretinal leakage from the partial 
fibrotic scar.
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